Revenue came in ahead of the market’s target. Q2 total revenue was $57.5 million versus a published consensus of roughly $55.3 million, a beat of about $2.2 million; RYTELO revenue also rose 11% sequentially to $57.5 million, supporting the commercial ramp. (Financial Highlights; Revenues)
| Metric | Q2 2026 | Q2 2025 / expectation |
|---|---|---|
| Total revenue | $57.5M (Financial Highlights) | $49.0M prior year; ~$55.3M consensus |
| Net loss | $(16.7)M (Income Statement) | $(16.4)M prior year |
| EPS | $(0.02) (Income Statement) | $(0.02) prior year; $(0.01) consensus |
| Total costs and operating expenses | $70.0M (Costs and Operating Expenses) | $61.5M prior year |
| Cash, equivalents, restricted cash and marketable securities | $326.9M (Cash and Marketable Securities) | $341.0M at March 31, 2026 |
| 2026 RYTELO revenue guidance | $220M–$240M (2026 Financial Guidance) | Reiterated, not raised |
| 2026 total operating expense guidance | $230M–$240M (2026 Financial Guidance) | Reiterated, not lowered |
The revenue beat did not translate into an earnings beat. EPS of $(0.02) missed the published $(0.01) consensus, while the net loss widened slightly year over year. The main drag was a sharp increase in cost of goods sold to $9.2 million from $1.2 million, largely tied to non-cash inventory-related expenses; this makes the bottom-line miss less reflective of cash economics, but it still leaves reported profitability below expectations. (Income Statement; Cost of Goods Sold)
The underlying commercial trend is constructive, but not newly upgraded. RYTELO demand increased 5% sequentially, ordering accounts rose roughly 8% to approximately 1,575, and first-half product revenue reached $109.2 million versus $88.4 million a year earlier. However, management merely reiterated the full-year revenue range rather than raising it, so the quarter improves confidence in execution without changing the company’s stated target. (Recent Business Highlights; Income Statement; 2026 Financial Guidance)
Cash remains adequate, but the company is still operating at a loss. Geron ended June with $326.9 million of cash and marketable securities, down from $341.0 million at March 31, while first-half net loss was $20.3 million. The filing says current resources plus anticipated RYTELO sales should fund operations for the foreseeable future, but the balance sheet did not strengthen during the quarter. (Cash and Marketable Securities; Income Statement)
Net read: a commercially solid but financially mixed quarter. The revenue beat and continued RYTELO demand growth are better than expected, but the EPS miss, higher manufacturing-related costs, and unchanged guidance keep this from being a clean positive surprise. The filing modestly improves the evidence that RYTELO is scaling, without materially raising the earnings or cash-flow outlook.
Read the original 8-K on SEC EDGAR ↗